More generally, the development of interventions would benefit greatly by research that improves understanding of the mechanisms underlying WD- or obesity-induced hippocampal pathophysiologies (e.g., BBB disruption, interference with glucose transport, inflammation, reduced BDNF) and whether they emerge independently or based on common underlying mechanisms. The gene discussed is BDNF; the disease is obesity due to melanocortin 4 receptor deficiency.